BackCymabay Therapeutics Overview
Cymabay Therapeutics Inc

Cymabay Therapeutics Discounted Cash Flow

DCF Analysis for CBAY.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$4.85

Current Fair Value

$4.85
85.1% Downside

Overvalued by 85.1% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading